Karin Dott
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
Papers in
- Co-authors
- Marie Paule Kiény (10 shared papers)Yves Rivière (3 shared papers)Jean‐Pierre Lecocq (7 shared papers)Luc Montagnier (4 shared papers)Marc Girard (4 shared papers)Andréa Pavirani (6 shared papers)Wilfried Dalemans (2 shared papers)Pascal Barbry (2 shared papers)
- Journals
- Protein Engineering Design and Selection (4 papers)Nature (3 papers)Virology (2 papers)Nature Biotechnology (2 papers)Thrombosis and Haemostasis (1 paper)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Karin Dott
24 papers receiving 2.0k citations
Karin Dott's Hit Papers
Peers
Comparison fields: 5 of 93
- Virology 796
- Infectious Diseases 392
- Pulmonary and Respiratory Medicine 567
- Immunology 377
- Hematology 127
Countries citing papers authored by Karin Dott
This map shows the geographic impact of Karin Dott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Dott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Dott more than expected).
Fields of papers citing papers by Karin Dott
This network shows the impact of papers produced by Karin Dott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Dott. The network helps show where Karin Dott may publish in the future.
Co-authors
The 25 scholars most cited alongside Karin Dott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation Hit paper breakdown → | 1991 | 608 |
| 2 | HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product Hit paper breakdown → | 1987 | 454 |
| 3 | 1997 | 197 | |
| 4 | 1988 | 106 | |
| 5 | 1990 | 101 | |
| 6 | 1986 | 89 | |
| 7 | 2001 | 78 | |
| 8 | 1985 | 76 | |
| 9 | 1991 | 71 | |
| 10 | 1988 | 48 | |
| 11 | 1988 | 41 | |
| 12 | 1995 | 38 | |
| 13 | 1989 | 24 | |
| 14 | 1992 | 19 | |
| 15 | 1993 | 17 | |
| 16 | 2000 | 17 | |
| 17 | 1987 | 17 | |
| 18 | 1991 | 17 | |
| 19 | Recombinant MUC 1 vaccinia virus: a potential vector for immunotherapy of breast cancer. | 1994 | 16 |
| 20 | 1987 | 10 |
About Karin Dott
Karin Dott is a scholar working on Genetics, Virology, Epidemiology, Molecular Biology and Hematology, having authored 24 papers that have together received 2.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (9 papers), HIV Research and Treatment (7 papers), Hemophilia Treatment and Research (5 papers), Herpesvirus Infections and Treatments (4 papers), HIV/AIDS drug development and treatment (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Hormonal Regulation and Hypertension (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Virology (796 citations), Infectious Diseases (392 citations), Pulmonary and Respiratory Medicine (567 citations), Immunology (377 citations) and Hematology (127 citations). Karin Dott has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Marie Paule Kiény, Yves Rivière, Jean‐Pierre Lecocq, Luc Montagnier, Marc Girard, Andréa Pavirani, Wilfried Dalemans, Pascal Barbry, Guy Champigny and Michel Lazdunski. Their work appears in journals such as Protein Engineering Design and Selection, Nature, Virology, Nature Biotechnology and Thrombosis and Haemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.